Ethylamine

Ethylamine

SCHEMBL4840928

[2H]C([2H])([2H])C([2H])([2H])N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylamine SCHEMBL25170202 0.95
Ethylamine SCHEMBL30965067 0.82
Ethylamine SCHEMBL29986744 0.80
Ethylamine SCHEMBL13800313 0.78
Ethylamine SCHEMBL13800312 0.74
Propylamine SCHEMBL31143850 0.70
Propylamine SCHEMBL1460798 0.70
Propylamine SCHEMBL19900118 0.68
Propane SCHEMBL1332567 0.63
Propane SCHEMBL3139620 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113788758-B Preparation method and preparation device of deuterated low-carbon amine 安徽昊帆生物有限公司 2024-09-17 CN claimed
CN-113788758-A Preparation method and preparation device of deuterated low-carbon amine 安徽昊帆生物有限公司 2021-12-14 CN claimed
EP-4561563-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Ensem Therapeutics, Inc. (US) 2025-06-04 EP disclosed
CN-113788758-B Preparation method and preparation device of deuterated low-carbon amine 安徽昊帆生物有限公司 2024-09-17 CN disclosed
WO-2024026129-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
CN-113788758-A Preparation method and preparation device of deuterated low-carbon amine 安徽昊帆生物有限公司 2021-12-14 CN disclosed
US-20120129849-A1 DEUTERATED SERINE-THREONINE PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-05-24 US disclosed
US-20100317655-A1 SULFONAMIDE INHIBITORS OF CARBONIC ANHYDRASE AUSPEX PHARMACEUTICALS, INC. (US) 2010-12-16 US disclosed
US-20090156671-A1 DEUTERIUM-ENRICHED OXYBUTYNIN PROTIA, LLC (US) 2009-06-18 US disclosed
US-7531685-B2 Deuterium-enriched oxybutynin PROTIA, LLC (US) 2009-05-12 US disclosed
US-20080299219-A1 DEUTERIUM-ENRICHED OXYBUTYNIN PROTIA, LLC (US) 2008-12-04 US disclosed
US-7425451-B2 Triazine derivatives as universal peptide isotope tag reagents (U-PIT) AGILENT TECHNOLOGIES, INC. (US) 2008-09-16 US disclosed
US-20070031973-A1 Triazine derivatives as universal peptide isotope tag reagents (U-PIT) ROBOTTI KARLA M 2007-02-08 US disclosed
US-7109040-B2 Modular isotope coding approach to proteomic analysis AGILENT TECHNOLOGIES, INC. (US) 2006-09-19 US disclosed
US-20050100956-A1 Modular isotope coding approach to proteomic analysis AGILENT TECHNOLOGIES, INC. 2005-05-12 US disclosed
US-20040115821-A1 Triazine derivatives as universal peptide isotope tag reagents (U-PIT) AGILENT TECHNOLOGIES, INC. 2004-06-17 US disclosed
EP-1429147-A1 Universal reagent for isotopically tagging peptides Agilent Technologies, Inc. (US) 2004-06-16 EP disclosed
EP-1429146-A1 Proteomic analysis Agilent Technologies, Inc. (US) 2004-06-16 EP disclosed